Expression of Insulin–Like Growth Factor Ii in Hepatitis B, Cirrhosis and Hepatocellular Carcinoma: Its Relationship With Hepatitis B Virus Antigen Expression
Open accessThe DOI matches its Crossref record.
Abstract
Expression of insulin–like growth factor II in two human hepatocellular carcinoma cell lines and in hepatitis B, cirrhosis and hepatocellular carcinoma in 419 cases were investigated, and its relationship with the expression of hepatitis B virus x gene was studied by means of immunohistochemical and electron microscopic techniques. The results demonstrated that hepatocellular carcinoma cells (SMMC 7721 and QGY 7703) in culture could express insulin–like growth factor II. Expression seemed to be regulated by cell density, which was suggested as the molecular basis of the contact inhibition of cell proliferation. In tissue sections, cells with high expression of insulin–like growth factor II were observed not only in hepatocellular carcinoma (93%) but also in 95% of the pericancerous liver tissues, 72% of cirrhotic livers, 64% of chronic active hepatitis and 37% of chronic persistent hepatitis. in most cases of hepatocellular carcinoma, insulin–like growth factor II was localized in the cytoplasm of the cancer cells. in the benign liver disorders, four types of cells that highly expressed insulin–like growth factor II were observed: (a) a kind of small liver cell we named the small polygonal liver cell ; (b) multinuclear giant hepatocytes; (c) hepatocytes in most of hyperplastic and neoplastic nodules, small hepatocyte nodules and some of regenerative nodules; and (d) some proliferating ductular cells. Even more interestingly, insulin–like growth factor II expression was shown to be closely related to the expression of hepatitis B virus x gene product. We suggest that the activation of insulin–like growth factor II gene and its overexpression may be a crucial step in the processes of hepatitis B virus—associated hepatocarcinogenesis and that the x gene product may activate the insulin–like growth factor II gene through a transactivation mechanism. in addition, we studied the characteristics of small polygonal liver cells , and the roles they may play in the regeneration and carcinogenesis of hepatitis B virus—infected liver are discussed. (Hepatology 1994;19:788-799).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Liver from bone marrow in humans
Theise, N. D., Nimmakayalu, M., Gardner, R., Illei, P. B., Morgan, G., Teperman, L., Henegariu, O., & Krause, D. S. (2000) · Hepatology · doi:10.1053/jhep.2000.9124 · Cited by 1,210
The canals of hering and hepatic stem cells in humans
Theise, N. D., Saxena, R., Portmann, B. C., Thung, S. N., Yee, H., Chiriboga, L., Kumar, A., & Crawford, J. M. (1999) · Hepatology · doi:10.1002/hep.510300614 · Cited by 702
Genomics and Signaling Pathways in Hepatocellular Carcinoma
Villanueva, A., Newell, P., Chiang, D., Friedman, S., & Llovet, J. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960171 · Cited by 556
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348
Progenitor Cells in Diseased Human Liver
(2003) · Seminars in Liver Disease · doi:10.1055/s-2004-815564 · Cited by 336
Metadata
- Authors
- Su, Q., Liu, Y.-F., Zhang, J.-F., Zhang, S.-X., Li, D.-F., & Yang, J.-J.
- Venue
- Hepatology
- Published
- 1994-10
- Volume
- 20
- Issue
- 4
- Pages
- 788-799
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2025933947
- Cited by
- 101
- References
- 0
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of Insulin–Like Growth Factor Ii in Hepatitis B, Cirrhosis and Hepatocellular Carcinoma: Its Relationship With Hepatitis B Virus Antigen Expression. https://app.cochat.ai/papers/10.1002/hep.1840200404
- The paper
- Su, Q., Liu, Y.-F., Zhang, J.-F., Zhang, S.-X., Li, D.-F., & Yang, J.-J. (1994). Expression of Insulin–Like Growth Factor Ii in Hepatitis B, Cirrhosis and Hepatocellular Carcinoma: Its Relationship With Hepatitis B Virus Antigen Expression. Hepatology. https://doi.org/10.1002/hep.1840200404
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.